Drug Firms Blasted for Hiding Antidepressant Data

audio iconMorning Edition audio

Sept. 10, 2004

In Capitol Hill hearings, lawmakers criticize drug manufacturers for failing to fully disclose data on the use of antidepressants by children, creating a misleading impression of the drugs' safety and effectiveness. The FDA is also faulted for being too passive a regulator. Hear NPR's Snigdha Prakash.

Related NPR Stories

Gauging Risks, Benefits of Prozac in TeensGauging Risks, Benefits of Prozac in Teens

Congressmen Criticize FDA over AntidepressantsCongressmen Criticize FDA over Antidepressants

Americans 'Worried' Over AntidepressantsAmericans 'Worried' Over Antidepressants

FDA Study Links Antidepressants, Teen SuicideFDA Study Links Antidepressants, Teen Suicide

Study Recommends Drugs and Talk for Teens with DepressionStudy Recommends Drugs and Talk for Teens with Depression

Treating Depression in AdolescentsTreating Depression in Adolescents

More Health & Science CoverageMore Health & Science Coverage

More Political CoverageMore Political Coverage

Web Resources

FDA Paper on Use of Antidepressant Drugs in Children